Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CASI Pharmaceuticals (CASI) Current Assets (2021 - 2025)

Historic Current Assets for Pharmaceuticals (CASI) over the last 5 years, with Q2 2025 value amounting to $18.2 million.

  • Pharmaceuticals' Current Assets fell 9995.12% to $18.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $18.2 million, marking a year-over-year decrease of 9995.12%. This contributed to the annual value of $39.6 million for FY2024, which is 9993.33% down from last year.
  • As of Q2 2025, Pharmaceuticals' Current Assets stood at $18.2 million, which was down 9995.12% from $27.2 billion recorded in Q1 2025.
  • Pharmaceuticals' 5-year Current Assets high stood at $61.0 billion for Q2 2023, and its period low was $18.2 million during Q2 2025.
  • Moreover, its 5-year median value for Current Assets was $73.4 million (2022), whereas its average is $20.5 billion.
  • Per our database at Business Quant, Pharmaceuticals' Current Assets surged by 8072480.97% in 2023 and then crashed by 9995.12% in 2025.
  • Pharmaceuticals' Current Assets (Quarter) stood at $62.0 million in 2021, then rose by 18.48% to $73.4 million in 2022, then soared by 80724.81% to $59.3 billion in 2023, then crashed by 99.93% to $39.6 million in 2024, then crashed by 54.11% to $18.2 million in 2025.
  • Its Current Assets stands at $18.2 million for Q2 2025, versus $27.2 billion for Q1 2025 and $39.6 million for Q4 2024.